Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Toshihiko Takata"'
Publikováno v:
The Japanese journal of antibiotics. 69(4)
We conducted the post-marketing surveillance of tebipenem pivoxil (Orapeneme fine granules 10% for pediatric), an oral carbapenem antibacterial agent, to investigate changes in bacterial susceptibility against tebipenem (TBPM). Bacterial strains used
Autor:
Takahisa Maruyama, Eiji Matsuhisa, Hiromi Meiji Seika Kaisha Ltd. Takata, Eiki Shitara, Katsuyoshi Iwamatsu, Yuko Kano, Toshihiko Takata, Yasuo Yamamoto, Mizuyo Kurazono, Kunio Atsumi
Publikováno v:
Bioorganic & Medicinal Chemistry. 15:6379-6387
A new series of 1β-methyl carbapenems possessing a 6,7-disubstituted imidazo[5,1- b ]thiazol-2-yl group directly attached to the C-2 position of the carbapenem nucleus was prepared, and the activities of these compounds against methicillin-resistant
Autor:
Takashi Ida, Takeshi Furuuchi, Yuko Tsutsumi, Akihiro Morinaka, Seiichi Inamura, Yoshihiro Takayama, Keiko Yamada, Yoshiaki Sakamaki, Toshihiko Takata, Takao Abe, Shiro Sakakibara, Nakako Tsujii
Publikováno v:
Antimicrobial agents and chemotherapy. 60(5)
Gram-negative bacteria are evolving to produce β-lactamases of increasing diversity that challenge antimicrobial chemotherapy. OP0595 is a new diazabicyclooctane serine β-lactamase inhibitor which acts also as an antibiotic and as a β-lactamase-in
Publikováno v:
Dermatology. 212:103-108
In order to estimate the clinical efficacy of a povidone-iodine oral antiseptic (PVP-I) on oral bacterial infectious diseases, we studied the effect of oral organic matter on the in vitro killing activity of PVP-I. In addition, we compared the in vit
Autor:
Yuichi Tsurusako, Yu Masuda, Toshihiko Takata, Satoshi Yorizane, Teruhiro Ogawa, Kazunori Nishizaki, Kunihiro Fukushima, Toshiaki Ogawara, Ken Nichi Sugata, Tomoko Nakashima
Publikováno v:
Acta Oto-Laryngologica. 119:67-71
Streptococcus pneumoniae is the micro-organism most frequently isolated from acute otitis media (AOM). Recently, drug-resistant or insensitive strains have been prevalent among pneumococcal AOM cases and were reportedly associated with persistent or
Autor:
Katsuyoshi Suzuki, Koji Kijima, Fumi Ito, Toshihiko Takata, Yukio Mikami, Kazunori Maebashi, Michiaki Unno, Hiroshi Kataoka, Yuko Muto, Atsuyuki Shimizu, Masashi Niida, Muneo Hikida, Kazunori Takeda, Shiro Sakakibara
Publikováno v:
Suizo. 23:542-544
Objectives It is known that prophylaxis with imipenem reduces the risk of infection accompanying severe acute pancreatitis. In this study,we modified a rat experimental model of severe acute pancreatitis for antibiotic evaluation, and the effect of b
Autor:
Toshihiko Takata, Kyoichi Totsuka, Takashi Yoshida, Yumiko Kanno, Kihachiro Shimizu, Takehiko Uchiyama
Publikováno v:
Journal of Infection and Chemotherapy. 3:49-54
We evaluated the combined effects of fosfomycin (FOM) with β-lactam antibiotics, including cefepime (CFPM), cefotaxime (CTX), cefminox (CMNX), cefotiam (CTM), cefazolin (CEZ), imipenem (IPM) and benzylpenicillin (PCG), against clinically-isolated pe
Publikováno v:
The Japanese journal of antibiotics. 62(2)
Tebipenem pivoxil (TBPM-PI), a novel oral carbapenem antibiotic, is a prodrug of tebipenem (TBPM). We assessed the pharmacokinetics of TBPM-PI fine granules at 250 mg as potency in healthy male volunteers in fasting and non-fasting states. Cmax of TB
Autor:
Akiko, Yoneyama, Masaki, Shimizu, Makiko, Tabata, Junko, Yashiro, Toshihiko, Takata, Muneo, Hikida
Publikováno v:
Dermatology (Basel, Switzerland). 212
In order to estimate the clinical efficacy of a povidone-iodine oral antiseptic (PVP-I) on oral bacterial infectious diseases, we studied the effect of oral organic matter on the in vitro killing activity of PVP-I. In addition, we compared the in vit
Autor:
Takeshi, Mikuniya, Toru, Hiraishi, Kazunori, Maebashi, Takashi, Ida, Toshihiko, Takata, Muneo, Hikida, Sakuo, Yamada, Naomasa, Gotoh, Takeshi, Nishino
Publikováno v:
The Japanese journal of antibiotics. 58(2)
The purpose of this study was to evaluate the possible benefit of fosfomycin (FOM) as prophylactic antibiotic in terms of antimicrobial activity and the potential of inducibility of beta-lactamase, compared with cefazolin, cefotiam, cefmetazole, and